title: Evidence for CTL-mediated selection of Tat and Rev mutants after the onset of the asymptomatic period during HIV type 1 infection.
abstract: The evolution of HIV-1 sequences over time is the result of the selection of mutant variants that have escaped from host immune responses or the outgrowth of mutants with increased viral replication, or both. We investigated the contribution of both selection processes to the overall evolution of the Tat and Rev regulatory gene sequences from four individuals, ranging in time from just prior to seroconversion to stable asymptomatic infection. After sequencing at least 15 clones per sample per gene, we analyzed the sequence evolution of the MHC-I motifs that were predicted from the MHC-I haplotypes of these patients. For each identified Tat sequence, we tested the activity of the corresponding encoded protein in a transactivation assay in vitro. Our results suggest that the evolution of the Tat and Rev sequences from these individuals can be explained by mutational escape of the MHC-I epitopes and that no mutations that replaced the original sequences in the viral population are associated with either an increase or decrease in Tat activity. CTL-mediated selection appears to be an important determinant of HIV-1 regulatory gene sequence evolution during the early stages of infection.
authors.affiliation: CNRS, FRE2736 CNRS/bioMérieux, IFR128 Biosciences-Lyon Gerland, Tour CERVI, 69007 Lyon, France. guillon@cervi-lyon.inserm.fr
authors.forename: C
authors.initials: C
authors.lastname: Guillon
authors.forename: K
authors.initials: K
authors.lastname: Stankovic
authors.forename: Y
authors.initials: Y
authors.lastname: Ataman-Onal
authors.forename: F
authors.initials: F
authors.lastname: Biron
authors.forename: B
authors.initials: B
authors.lastname: Verrier
mesh_terms: D000595:Amino Acid Sequence; D000939:Epitopes; D019143:Evolution, Molecular; D015694:Gene Products, rev / Q000235:genetics* / Q000276:immunology; D015696:Gene Products, tat / Q000235:genetics* / Q000276:immunology; D015757:Genes, rev / Q000235:genetics / Q000276:immunology; D015756:Genes, tat / Q000276:immunology; D015658:HIV Infections / Q000235:genetics*; D006679:HIV Seropositivity / Q000235:genetics / Q000821:virology; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D008969:Molecular Sequence Data; D012641:Selection, Genetic; D016415:Sequence Alignment; D013602:T-Lymphocytes, Cytotoxic / Q000821:virology*; D014779:Virus Replication; D054321:rev Gene Products, Human Immunodeficiency Virus; D054322:tat Gene Products, Human Immunodeficiency Virus
chemical_list: D000939:Epitopes; D015694:Gene Products, rev; D015696:Gene Products, tat; D054321:rev Gene Products, Human Immunodeficiency Virus; D054322:tat Gene Products, Human Immunodeficiency Virus